---
figid: PMC10296738__cells-12-01604-g003
pmcid: PMC10296738
image_filename: PMC10296738__cells-12-01604-g003.jpg
figure_link: /pmc/articles/PMC10296738/figure/F3/
number: Figure 3
figure_title: Estradiol effects on liver.
caption: Estradiol effects on liver. (A) Low levels of estrogen are associated with
  liver pathology in females via increased fat storage, impaired glucose and TCA cycle
  pathways; (B) Impaired estrogen signaling is associated with liver pathology in
  males. Low estrogen promotes liver disease via impaired glucose metabolism. High
  levels of estrogen promote NAFLD development via T2D. NAFLD, non-alcoholic fatty
  liver disease; NASH, non-alcoholic steatohepatitis; MetS, metabolic syndrome; T2D,
  type 2 diabetes; LDL-C, circulating low-density lipoprotein; HDL-C, circulating
  high-density lipoprotein; PPAR-Î³, peroxisome proliferator-activated receptor gamma;
  GLUT, glucose transporters; PDH E1B, pyruvate dehydrogenase E1 beta; PDHE2, pyruvate
  dehydrogenase complex subunit E2; E2, estradiol
article_title: The Influence of Sex Hormones in Liver Function and Disease
citation: Alvile Kasarinaite, et al. Cells. 2023 Jun;12(12).
year: '2023'
pub_date: 2023-6-
epub_date: 2023-6-11
doi: 10.3390/cells12121604
journal_title: Cells
journa_nlm_ta: Cells
publisher_name: MDPI
keywords:
- liver
- NAFLD
- sex hormones
- estrogen
- testosterone
- HRT
- immune response
- in vitro models
- human PSCs
- tissue engineering
---
